Therefore, in vitro test on breast cancer cells harboring the active FFL (PDGF/FLT1/SHC1) using small molecule inhibitor drugs such as sunitinib, which also targets the PDGF receptors, could be an interesting validation experiment in the future. Here, SHC1 is linked to breast carcinoma.